Trial record 1 of 1 for:    CA220-007
Previous Study | Return to List | Next Study

Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01489059
Recruitment Status : Completed
First Posted : December 9, 2011
Last Update Posted : August 29, 2014
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2014
  Actual Study Completion Date : June 2014